CTRI/2020/03/023893Not yet recruiting未知
Clinicopathological study of adverse cutaneous drug reactions
Dr Amulya s0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •A clinical and histological study of patients who present to the father muller hospital opd or in admission who are clinically diagnosed as adverse cutaneous drug reactions.
Exclusion Criteria
- •1) age below 12 years
- •2) patients who refuse to be included in the study
- •3) patients who are not clinically diagnosed as adverse cutaneous drug reaction
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Correlation between the appearance of fungal infection on skin and the fungal species causing it among children.CTRI/2020/12/029992Father Muller Medical College
Not yet recruiting
Phase 2
Comparison of two treatment options for patients with precursor lesions of skin cancer: colchicine cream versus 5-FU creamL57.0Actinic keratosisRBR-487ctpInstituto Lauro de Souza Lima (ILSL)
Completed
Not Applicable
Study for association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersiometastatic renal cell cancerJPRN-UMIN000018948Department of Pharmacy, Kobe University Hospital30
Recruiting
Not Applicable
ong-term prognosis of severe cutaneous adverse drug reactioStevens-Johnson syndrome Toxic epidermal necrolysis Drug-induced hypersensitivity syndromeJPRN-UMIN000009710Yokohama City University Graduate School of Medicine100
Active, not recruiting
Not Applicable
Assessment of skin irritability.Wounds and injuriesEstheticsF02.463.785.477RBR-6hnmxvIpclin - Pesquisa Clínica Integrada